Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targetsBenjamin A. Nacev, William D. Tap, Francisco Sánchez-Vega et al.|Nature Communications|2022Cited by 219
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced SarcomaCiara M. Kelly, Sandra P. D’Angelo, William D. Tap et al.|Clinical Cancer Research|2023Cited by 71
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcomaSandra P. D’Angelo, William D. Tap, Allison L. Richards et al.|Nature Communications|2022Cited by 61
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single centerEvan Rosenbaum, Sandra P. D’Angelo, Cristina R. Antonescu et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 58
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway GenesEvan Rosenbaum, William D. Tap, Philip Jonsson et al.|JCO Precision Oncology|2020Cited by 44